Dr. Jonathan Nowak, MD, PhD is a molecular and gastrointestinal pathologist at Brigham and Women’s Hospital and the Dana-Farber Cancer Institute, and assistant professor of pathology at Harvard Medical School.  He specializes in the molecular characterization of solid tumors, with a specific focus on pancreatic and colorectal cancer, and runs a joint laboratory with Dr. Brian Wolpin focused on tissue-based analysis of human pancreatic cancer specimens.

Dr. Nowak earned his medical degree from the Weill Medical College of Cornell University and his doctorate of philosophy at The Rockefeller University as part of the Tri-Institutional Weill Cornell/Rockefeller/Sloan-Kettering MD-PhD Program.  His graduate work in the laboratory of Dr. Elaine Fuchs identified the embryologic origin of skin epithelial stem cells and the transcriptional program necessary for their specification. He completed his pathology residency at Brigham and Women’s Hospital and fellowships at Harvard Medical School and Brigham and Women’s Hospital. He is board-certified in anatomic and clinical pathology and molecular genetic pathology. As a molecular pathologist, Dr. Nowak helps design and interpret next generation sequencing assays for clinical tumor characterization. He also leads a newly established constitutional genetics testing service focused on hereditary cancer predisposition. Dr. Nowak joined the faculty of Harvard Medical School, Brigham and Women’s Hospital, and the Dana-Farber Cancer Center in 2016.